Search Within

Victor Fedorov

Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Center for Hematologic Malignancies (5)
  2. Department of Medicine (5)
  3. GSK Faculty (5)
  4. Hematologic Malignancies Research (5)
  5. Hematologic Malignancies, Division of (5)
  6. Molecular Pharmacology and Chemistry Program Faculty (5)

More Groups

People
  1. Michel Sadelain (5)
  2. Maria Themeli (4)
  3. Christopher Kloss (2)
  4. Fabiana Perna (1)
  5. Giovanni Ciriello (1)
  6. Mithat Gonen (1)
Years
  1. 2014 (2)
  2. 2013 (4)
Publications
  1. Experimental Hematology (1)
  2. Haematologica (1)
  3. Nature Biotechnology (1)
  4. Proceedings of the National Academy of Sciences of the United States of America (1)
  5. Science Translational Medicine (1)
  6. The Cancer Journal (1)
Publishers
  1. American Association for the Advancement of Science (1)
  2. Elsevier Science, Inc. (1)
  3. Ferrata Storti Foundation (1)
  4. Lippincott Williams & Wilkins (1)
  5. National Academy of Sciences (1)
  6. Nature Publishing Group (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Icars: Engineered safety for T cell immunotherapy
    Meeting Abstract

    Fedorov, V.; Themeli, M.; Sadelain, M.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Novel approaches to enhance the specificity and safety of engineered T cells
    Journal Article

    Fedorov, V. D.; Sadelain, M.; Kloss, C. C.
    The Cancer Journal (2014)

    Fulltext@MSK | Save
  • PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses
    Journal Article

    Fedorov, V. D.; Themeli, M.; Sadelain, M.
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
    Journal Article

    Themeli, M.; Kloss, C. C.; Ciriello, G.; Fedorov, V. D.; Perna, F.; Gonen, M.; Sadelain, M.
    Nature Biotechnology (2013)

    Fulltext@MSK | Save
  • Inhibitory chimeric antigen receptors (ICARS) limit undesirable side effects of T-cell therapies
    Meeting Abstract

    Fedorov, V.; Themeli, M.; Sadelain, M.
    Experimental Hematology (2013)

    Fulltext@MSK | Save
  • Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelialto-mesenchymal transition in breast cancer cells
    Journal Article

    Stadler, S. C.; Vincent, C. T.; Fedorov, V. D.; Patsialou, A.; Cherrington, B. D.; Wakshlag, J. J.; Mohanan, S.; Zee, B. M.; Zhang, X.; Garcia, B. A.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2013)

    Fulltext@MSK | Save